News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AstraZeneca PLC (AZN), Bristol-Myers Squibb Company (BMY) Recall Bydureon Diabetes Drug for Under-Filled Vials


9/20/2013 7:15:50 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AstraZeneca PLC ( AZN ) and Bristol-Myers Squibb Co. ( BMY ) have recalled about 92,000 vials of their jointly marketed Type 2 diabetes treatment Bydureon in several European countries because some vials weren't fully filled with the long- acting medication. The affected batches were recalled in the U.K., Germany, Romania, the Netherlands, Ireland, Sweden, Finland and Spain, said a Bristol-Myers spokesman. No batches distributed in other markets were affected and the companies don't expect any supply issues, he said.

Help employers find you! Check out all the jobs and post your resume.

Read at Wall Street Journal
Read at Nasdaq


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES